Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
10 participants
OBSERVATIONAL
2016-09-30
2018-03-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
OCT Vibrography for Biomechanical Properties of Tissues
NCT05759780
Visual and Functional Assessment in Low Vision Patients
NCT01876147
Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging
NCT01717937
Non-Invasive Imaging of the Human Eye
NCT02432898
Effect of Panretinal Photocoagulation on Optic Nerve Head Topography
NCT00767884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Healthy participants will receive a one-time assessment of quantitative Magnetic Resonance Imaging (MRI) and spectrum domain optical coherence tomography (OCT).
magnetic resonance image (MRI)
Radiographic imaging that takes about 30-45 minutes
Optical Coherence Tomography (OCT)
Images taken from the back of the eye (retina)
optic neuropathy group
Participants with optic neuropathy will receive a one-time assessment of quantitative Magnetic Resonance Imaging (MRI) and spectrum domain optical coherence tomography (OCT).
magnetic resonance image (MRI)
Radiographic imaging that takes about 30-45 minutes
Optical Coherence Tomography (OCT)
Images taken from the back of the eye (retina)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
magnetic resonance image (MRI)
Radiographic imaging that takes about 30-45 minutes
Optical Coherence Tomography (OCT)
Images taken from the back of the eye (retina)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with optic neuropathy(10) and age controlled healthy subjects(10)
Exclusion Criteria
* For healthy control group: History of systemic disease except hypertension.
* Pregnant women and prisoners will be excluded.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Byron Lam
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Byron R Lam, MD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bascom Palmer Eye Institute
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20160376
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.